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ABSTRACT:
The microenvironment of cells controls their phenotype, and thereby the
architecture of the emerging multicellular structure or tissue. We have reported
more than a dozen microenvironmental factors whose signaling must be integrated
in order to effect an organized, functional tissue morphology. However, the factors
that prevent integration of signaling pathways that merge form and function are still
largely unknown. We have identified nuclear factor kappa B (NFkB) as a transcriptional
regulator that disrupts important microenvironmental cues necessary for tissue
organization. We compared the gene expression of organized and disorganized
epithelial cells of the HMT-3522 breast cancer progression series: the non-malignant
S1 cells that form polarized spheres (‘acini’), the malignant T4-2 cells that form large
tumor-like clusters, and the ‘phenotypically reverted’ T4-2 cells that polarize as a
result of correction of the microenvironmental signaling. We identified 180 genes that
display an increased expression in disorganized compared to polarized structures.
Network, GSEA and transcription factor binding site analyses suggested that NFkB is a
common activator for the 180 genes. NFkB was found to be activated in disorganized
breast cancer cells, and inhibition of microenvironmental signaling via EGFR, beta1
integrin, MMPs, or their downstream signals suppressed its activation. The postulated
role of NFkB was experimentally verified: Blocking the NFkB pathway with a specific
chemical inhibitor or shRNA induced polarization and inhibited invasion of breast
cancer cells in 3D cultures. These results may explain why NFkB holds promise as a
target for therapeutic intervention: Its inhibition can reverse the oncogenic signaling
involved in breast cancer progression and integrate the essential microenvironmental
control of tissue architecture.

INTRODUCTION

organ specificity of cancer [1, 2]. Disruption of polarized
tissue structure [3-5] and induction of cellular invasion
are accompanied by extensive changes in the cellular
microenvironment; in many cases the basement membrane
is degraded, cell-extracellular matrix (ECM) adhesion is
altered and growth-regulatory signals are lost as a result.
This microenvironmental remodeling and the consequent

Cancer is an organ specific disease. It is widely
accepted that the loss of growth regulation is the central
mechanism shared by all cancers. We have argued that the
tissue architecture is at least an equally important regulator
of malignant transformation, and one that may explain
www.impactjournals.com/oncotarget
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changes in tissue structure contribute to the development
of a malignant phenotype [5, 6]. Over two decades ago
we developed a 3-dimensional (3D) culture system using
laminin-rich ECM (lr-ECM) to distinguish normal and
malignant breast phenotypes [7]. In 3D cultures, nonmalignant HMT-3522 S1 (S1) cells form polarized,
growth-arrested spheres, which closely resemble the
alveolar structures of healthy breast tissues referred to
as acini [8]. We have extended the series to characterize
premalignant phenotype of additional cell-lines referred
to as S3 series [9]. We have used these assays to identify
and characterize the microenvironmental factors and
signals controlling acquisition of a malignant phenotype
and its reversal [7, 10-12] (for further references see
[2]). The isogenic malignant counterpart of S1 cells, the
HMT-3522 T4-2 (T4-2) cells, display an altered profile of
microenvironmental receptors and downstream signaling,
and form disorganized, proliferative structures displaying
enhanced cell invasion under the same conditions [10, 12]
(and references cited above).
In addition to differences in tissue organization,
compared to their S1 counterparts, the malignant T4-2 cells
have significantly higher expression of epidermal growth
factor receptor (EGFR), phosphatidylinositol 3-kinase
(PI3K), mitogen-activated protein kinase (MAPK) as
well as beta1-integrin and matrix metalloproteinases
(MMPs) such as MMP9 among others [5, 9, 10, 12].
We have repeatedly shown that by manipulating the
microenvironmental signals in T4-2 and other malignant
cells [12], the cells can be induced to form polarized, noninvasive structures resembling those formed by the nonmalignant S1 cells (‘T4-2R’ cells). We have referred to
this phenomenon as ‘phenotypic reversion’ [10].
Decreasing activation of any of the above pathways
down-modulates their downstream signals, normalizes
the signaling through all the other pathways and reverses
the malignant phenotype of T4-2 cells in 3D culture. We
know also that changes in glucose uptake play an equally
important role in both disorganization and reversion [13].
Thus many seemingly disparate agents and mechanisms
induce a common phenotypic change (reversion of the
chaotic malignant phenotype to an organized acinar-like
structure) if the cells are in a physiologically relevant 3D
microenvironment.
This observation led us to hypothesize that
depending on the microenvironmental signaling, the
cells must experience changes in their transcriptional
programs that accompany the observed changes in colony
architecture. We also hypothesized that there would
be one or more common transcriptional regulators that
integrate the signals to effect this switch. To find such
regulators, we used microarray data of non-malignant S1
and malignant T4-2 cells, as well as data that had been
obtained for T4-2 cells ‘phenotypically reverted’ by the
widest variety of inhibitors, and compared the common
denominators. These analyses identified the transcription
www.impactjournals.com/oncotarget

factor nuclear factor-kappa B (NFkB) as a prominent
switch for regulating the change between disorganization
and polarity in response to microenvironmental changes.
NFkB regulates a number of cancer-related
processes including immune-response, inflammation, cell
survival and cancer progression [14]. The NFkB family
consists of five structurally and functionally conserved
members in mammalian cells, including RELA (p65),
RELB (p60), c-REL, NFkB1 (p105 and p50), and NFkB2
(p100 and p52) [15]. Elevated NFkB binding activity
has been observed in both primary human breast cancer
tissues and breast cancer cell lines, and contributes to the
activation of CYCLIN D1, c-MYC, and MUC1 [16-18].
Despite considerable literature suggesting the importance
of NFkB in cancer in general and in breast cancer in
particular, the reasons behind its dominant activation
in tumors are still undefined. We find that NFkB acts
as a transcriptional rheostat the level of which directs a
phenotype of order and its aberrant expression spells
architectural disorder in response to microenvironmental
changes. This finding could provide a fine-tuning of a
framework for designing more compelling therapeutics.

RESULTS
Comparison of malignant disorganized colonies
with organized acini identified a set of genes
common in reversion.
We showed previously that the modification of
aberrant microenvironmental signaling in malignant
human mammary epithelial cells (HMECs) reprograms
them to form polarized, growth-arrested structures in 3D
cultures [10, 12] (Figure 1A). To identify the alterations
in gene expression profiles associated with such
reprogramming events, we utilized microarrays of S1, T42, and T4-2R cells reverted by inhibitors of EGFR, beta1integrin, MAPK, PI3K and by broadband inhibitors of
MMPs as well as by reduced glucose metabolism (Figure
1B and Supplemental Table 1, GEO database, GSE50444).
We obtained a gene expression matrix with data from 6560
genes and 24 microarrays – 5 of S1, 5 of T4-2 and 14 of
T4-2, reverted with different agents (Supplemental Table
2). Unsupervised hierarchical clustering analysis showed
that S1, T4-2 and T4-2R cells each cluster together
(Supplemental Figure S1).
We identified a set of 345 genes that were
differentially expressed in cells with different 3D
phenotypes – polarized or disorganized - (LIMMA/R
Bioconductor,p=0.005). The genes upregulated in T4-2
cells (180 genes) were called ‘disorganization gene
signature’ (Supplemental Table 3). Genes that were
upregulated in S1 cells and reverted T4-2 cells (165
genes) were referred to as ‘organization gene signature’.
2011
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NFkB associated with
disorganization genes.

We used the disorganization gene signature for further
analysis in order to find transcriptional regulators involved
in the disturbance of acinar structure in T4-2 cells. The
expression and hierarchical clustering of these genes is
depicted in Fig. 1C.
Using the statistics gene ontology tool DAVID [19],
we identified genes encoding proteins located in adherens
junctions and the actin cytoskeleton as well as genes
involved in processes such as cell adhesion, focal adhesion
and actin cytoskeleton organization, that were significantly
enriched in the disorganization gene signature (Figure
1D). We also found that genes involved in cell migration
were overrepresented, consistent with a previous report
correlating disruption of tissue polarity with endothelial
cell migration [20]. Furthermore, gene set enrichment
analysis (GSEA, [21]) of the gene expression matrix
confirmed an increase in expression of actin organization
in T4-2 cells (p=0.002).

A

the

expression

of

In order to identify common signaling pathways
and/or transcription factors involved in the disorganization
of the 3D structures, we employed several bioinformatics
tools. Comparison of HMT-3522 expression profiles with
identified gene sets (Gene Set Enrichment Analysis, [21])
revealed that genes related to the ‘positive regulation of
IKK and NF-κB cascade’ are activated in disorganized
T4-2 cells (p<0.09, Figure 2A). Using the network analysis
tool Cytoscape, we identified a regulatory network
associated with the differentially expressed genes. p65, i.e.
one of the subunits of NFkB, was one of the major hubs
of the network with more than 100 neighbors (Figure 2B).
Most notably, transcription factor binding site analysis of
the disorganization cluster using TransFind (transfind.sysbio.net/, [22]) identified NFkB as a potential transcription
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Figure 1: A cluster of genes revealed by microarray analysis is associated with tissue polarity in HMT3522 cell lines.

A) Immunofluorescence analysis of basal marker alpha6-integrin in S1, T4-2, and T4-2 cells phenotypically reverted in 3D culture. S1
and reverted T4-2 cells formed polarized spheroids, but T4-2 cell formed disorganized structures. Blue:DAPI, green: alpha6 integrin.
Scale: 25µm B) Scheme showing the pathways that were blocked to reverse the malignant phenotypes of T4-2 cells in 3D culture for the
microarray analysis. C) Unsupervised clustering of the 180 genes upregulated in T4-2 cells as compared to S1 cells and reverted T4-2
cells. D) Gene Ontology terms (biological processes, cell components, molecular functions) and KEGG pathways overrepresented in the
disorganization gene signature.
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factor for the disorganization genes with the third highest
significance (p<0.005); 24 of the 180 genes were identified
as potential NFkappaB target genes (Supplemental Table
3, marked in yellow). This corresponds to a percentage 1.8
times as high as in the total set of 6560 genes.

These results suggest that NFkB is a potential
regulator of the disorganization genes, and that activation
of NFkB may be associated with disruption of polarized
mammary tissue structure.

A

B

Figure 2: GSEA and network analyses reveal NFkB as a potential regulator of disorganization genes. A) Gene set

enrichment analysis [21] finds the gene set ‘positive regulation of IKK and NFkB cascade’ to be enriched among genes that show a
high expression in unorganized cells (1:’negatively correlated’) and low expression in organized cells in the microarrays (0:’positively
correlated’) (p=0.09). B) A regulatory network consisting of the 180 genes of the disorganization signature as well as connecting nodes
that interact with at least two disorganization genes was identified using Cytoscape. Red nodes: disorganization genes, light blue nodes:
connecting genes, green edges: interactions found in NCBI, dark blue node: p65.
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Figure 3: The NFkB pathway is activated in disorganized T4-2 cells compared to polarized S1 and reverted T4 cells. A)

Immunoblotting analysis of p65 expression in S1, T4-2, and reverted T4-2 cells in 3D culture. Laminin A/C was used as a loading control.
T4-2 cells were reverted by tyrphostin (Tyr), an EGFR inhibitor; LY294002 (LY), a PI3K inhibitor; GM6001 (GM), a MMP inhibitor; 2DG,
a glucose metabolism inhibitor; VPA, a HDAC inhibitor; AIIB2, a β1 integrin blocking antibody, MAB225 (MAB), an EGFR blocking
antibody. B) Immunoblotting analysis of phosphorylated p65 in S1, T4-2, and T4-2 cells reverted by tyrphostin. The blot results were
quantified by AlphaEaseFC software, and expressed as relative levels of phosphorylated p65 to total p65. C) Immunoblotting of nuclear
protein extracted from S1, T4-2, and T4-2 cells reverted with tyrphostin. D) Luciferase analysis of NFkB transcription activities in T4-2
and reverted T4-2 cells. Graph displays average ± SEM; n=4.
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Expression and activation of NFkB is associated
with the disorganized tissue phenotype.

cells (Figure 3A), suggesting that microenvironmental
cues contribute to NFkB activation in the disorganized
HMECs.
It has been reported that p65 is phosphorylated at
Ser536 by IkappaB kinase (IKK), NFkB activating kinase,
and Ribosomal S6 kinase 1 (RSK1), which in turn induces
nuclear translocation of p65 [23]. Thus, we analyzed the
phosphorylation at Ser536 and nuclear levels of p65.
Quantification of immunoblotting results showed that
Ser536 phosphorylation of p65 was increased in T4-2 cells
and repressed in S1 and reverted T4-2 cells (Figure 3B).
In addition, nuclear translocation of p65 was consistent
with phosphorylation status (Figure 3C). In order to
assess the NFkB activity in T4-2 and reverted T4-2 cells
directly, we measured the luciferase activity in cells stably
transfected with a luciferase reporter construct that is
controlled by NFkB response elements. We found that
the transactivation activities of NFkB were significantly
reduced in T4-2 cells reverted by the EGFR inhibitor
(Figure 3D). In summary, we find the malignant phenotype
associated with higher levels of p65 mRNA, p65 protein
levels as well as increased NFkappaB transcriptional
activity.

To confirm that NFkB is indeed activated in
disorganized MECs compared to polarized cellular
structures, we assessed the expression of the NFkB
subunit p65 in S1, T4-2, and reverted T4-2 cells. We found
that mRNA levels of p65 were significantly upregulated
in disorganized T4-2 cells compared to polarized S1
cells or reverted T4-2 cells. Interestingly, p65 is one of
the 180 genes of the disorganization signature in T4-2
cells (Supplemental Figure S2). Among the 25 genes
with the highest correlation of expression with p65, there
were three genes involved in ECM-receptor interaction,
alpha6-integrin, beta4-integrin and thrombospondin
(with correlation coefficients of 0.91, 0.87 and 0.86
respectively), indicating a tight connection between
their expression and p65 (data not shown). p65 was also
increased at the protein level in untreated T4-2 cells
compared to S1 cells. Reversion of T4-2 cells by blocking
of EGFR, beta1-integrin, MMP, and their downstream
signals drastically reduced the expression of p65 in those
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Figure 4: Inhibition of the NFkB pathway reverses the malignant phenotypes of T4-2 cells in 3D culture. A) Phase

and immunofluorescence images of T4-2 cells. Cells were either treated with NFkB inhibitor (Wedelolactone, 10 µM) and cultured in
3D for four days orinfected with p65 shRNA lentivirus before plating in 3D culture. Blocking the NFkB pathway reprograms the cells to
form polarized spheroids structure. Green: alpha6-integrin. Scale: 25µm. B) Immunoblotting analysis of beta1-integrin, EGFR and p65
expression in control and p65 shRNA-expressing T4-2 cells. C) Transwell invasion analysis of control and p65 shRNA-expressing T4-2
cells. Graph displays average ± SEM; n=3. D) Quantification of mRNA levels of NFkB target genes by real-time PCR. Control and p65
shRNA-expressing T4-2 cells were cultured in 3D for 4 days before RNA extraction.
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Downmodulation of NFkB leads to phenotypic
reversion.

provides a ‘disintegration node’ in a 3D tissue-like setting.

The expression of the disorganization genes
correlates also with the phenotype of other breast
cancer cell lines in 3D.

To show that inhibition of NFkB indeed leads to
phenotypic reversion, we blocked NFkB activation in
T4-2 cells by two means. T4-2 cells cultured on top of
3D laminin-rich ECM (lrECM) gels for four days were
treated with Wedelolactone, an IKK inhibitor [24].
The Wedelolactone-treated cells formed small spheroid
structures with basal polarity (alpha6-integrin), whereas
the vehicle-treated control cells remained as disorganized,
larger structures (Figure 4A). We also utilized shRNA to
reduce p65 expression in T4-2 cells (Figure 4B). Reducing
p65 expression reprogrammed T4-2 cells to form polarized
spheroids structures in 3D cultures (Figure 4A), and cell
invasion was significantly suppressed (Figure 4C). Using
quantitative RT-PCR, we measured several NFkB -targeted
genes to compare the NFkB activity in control vs. p65
knockdown cells. Our results showed significant reduction
in mRNA levels of SERPINA1, TNFSF12A, PLAT, DUSP,
MMP19, and TNFSF9 after downregulation of p65 (Figure
4D). As expected from our previous data, we found that
the protein levels of beta1-integrin and EGFR were also
decreased in p65 knockdown cells (Figure 4B). NFkB
B
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D
Invaded cell

3.0
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The 3D morphologies of a substantial panel of
human breast cancer cell lines correlate with their
gene expression profiles in 3D cultures and tumor
cell invasiveness [25]. Since mRNA levels of the 180
disorganization genes are associated with tissue structure
in the HMT-3522 cell lines, we sought to determine
whether these genes are similarly associated with 3D
morphologies of other breast cancer cell lines. Comparing
the average expression of the disorganization genes in 24
breast cancer cells lines, we found a higher expression in
basal cell lines than in luminal cell lines (Supplemental
figure S3). Unsupervised hierarchical clustering analysis
of the disorganization gene set revealed a correlation of
expression with subtype as well as 3D morphology. Basal
B cell lines clustered together with higher expression of
disorganization genes compared to luminal cell lines.
Within the basal B cluster (I), the majority of the cancer
cells with stellate morphology grouped together (Figure
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Figure 5: Expression of disorganization genes and activation of the NF-κB pathway are associated with aggressive 3D
phenotypes of multiple breast cancer cell lines. A) Unsupervised hierarchical clustering of breast cancer cell lines in 3D culture

using the 180 disorganization genes. Each row represents a gene; each column represents a cell line. B) Bar graph of RelB mRNA levels
in basal and luminal types of breast cancer cell lines. RelB mRNA expression is assessed by Affymetrix microarray and measured as log2
(probe intensities). C) Phase and immunofluorescence images of BT549 cells. Cells were either treated with Wedelolactone in 3D culture
for 4 days or infected with RelB shRNA retrovirus before being seeded in 3D culture. D) Transwell invasion analysis of BT549 cells. The
cells were treated with NF-κB inhibitor (Wedelolactone, 10 µM) or transfected with RelB shRNA vector.
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DISCUSSION

5A). Most of the cell lines in the second cluster (II) are
luminal and basal A subtypes with spheroid 3D, mass
or grape-like phenotypes. The majority of basal B cells
form stellate structure in 3D culture and lack E-cadherin
expression, reflecting decreased cell–cell interactions and
enhanced invasion [25]. Therefore, the up-regulation of
disorganization genes seems associated with aggressive
morphologies and increased cell invasion in 3D cultures.
To examine whether NFkB activity is functionally
involved in the 3D phenotypes of other breast cancer
cell lines, we chose BT549, a basal cancer cell line with
a stellate morphology. It was treated with Wedelolactone
in 3D culture. Most of the Wedelolactone-treated cells
formed round or mass structures in 3D lrECM gels
(Figure 5C). The colony structures were more organized
in drug-treated cells as shown by beta-catenin and nuclear
staining, although the metastatic cells were not fully
polarized (Figure 5C), as was the case for MDA-MB-231
cells which require more than one inhibitory factor to
be fully reverted [12]. The dramatic changes in tissue
structures were accompanied by a significant reduction
in cell invasion (Figure 5D). Since mRNA levels of the
NFkB subunit RELB are elevated in basal-type breast
cancer cells (Figure 5B), NFkB signals in those cells can
also be blocked with shRNA targeting the RELB gene.
We found that in 3D culture, RELB-silenced BT549 cells
form structures with reduced invasive branches which
we termed ‘mass’ (Figure 5C and supplemental Figure
S4) [25] . In addition, knockdown of RELB significantly
inhibited invasion of BT549 cells (Figure 5D). These
results indicate the involvement of NFkB pathway in
invasion of basal-type breast cancer cells in 3D gels.

Loss of tissue organization is a trait of every
malignant tumor, but growth rather than architecture
has traditionally been accepted to be the most important
hallmark of cancer. Yet for more than a decade we have
shown repeatedly that the architecture of the breast
acini in 3D cultures can be dominant over the malignant
genome, i.e. the cancer cell phenotype and growth status
can be reversibly altered if the architecture is restored via
microenvironmental signaling [1, 2]. This reversibility
in the absence of genetic changes [26] implies that
the phenotype is linked to the regulatory status and
relatively unaffected by the genetic composition of the
cells. Interestingly, within the same malignant cells, the
inhibition of many different signaling pathways leads to a
similar organized phenotype [3] . Because of reversibility
and commonality of phenotype, we postulated that the
dramatic change seen with multiple reverting agents could
indicate the existence of specific molecular ‘nodes’ that
control architectural reorganization in response to this
great variety of microenvironmental factors.
Our analyses revealed that the extensive common
differences in the gene expression profile of cells
with an organized and disorganized phenotype in
mammary epithelial cells are associated with at least one
transcriptional regulator, NFkB. This makes NFkB one of
the critical nodes through which the microenvironmental
signaling pathways pass/integrate. When NFkB is
suppressed, the architecture is maintained and tissues
remain functional. Should the microenvironmental
signaling be disrupted, NFkB becomes activated, and both
tissue polarity and normal functions become imbalanced.
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Figure 6: A scheme showing the role of NF-κB as potential integrator of various microenvironmental cues and regulator
of multicellular organization.
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In our studies blocking NFkB with a chemical inhibitor
or shRNA was sufficient for the reestablishment of basal
polarity in malignant cells; conversely in all conditions
where malignant breast cancer cells were ‘reverted’, NFkB
levels were decreased.
NFkB has been shown to be involved in the
development and progression of breast cancer: It is
frequently highly activated in mammary tumors, in
particular within disorganized ER-negative tumors where
it has been reported to promote cancer progression by
enhancing cancer cell survival and proliferation [27, 28].
To this list we now add an additional important function
of NFkB as an important player in loss of tissue polarity
and organization. It was shown previously that modulation
of many different oncogenic pathways including EGFR,
PI3K and integrin signaling leads to changes in NFkB
activity [29-35]. Also, activation of the NFkB pathway
is required for induction and maintenance of EMT
in mammary tumors [36]. In our 3D model, downmodulation of all these pathways leads to a reorganized
phenotype, and our analysis suggests that NFkB is a
major molecular linker between these pathways and
tissue architecture: Of the 24 genes that are upregulated
in disorganized cell clusters and that have potential NFkB
binding sites in their promotor region (Supplemental
Table 3, marked in yellow), four genes were associated
with actin cytsoskeletal organization, cell junction and cell
adhesion in the GO database (ACTN1,EPB41L2, GNE,
PANX1).
This has strong implications for NFkB in cancer
prevention and as target for therapeutic efforts: If
keeping NFkB balanced is the key to healthy mammary
tissues, signaling gone awry in malignant cells can be
compensated through reducing other stimuli activating
NFkB, including reductions in stress and inflammation. As
long as NFkB is high, integration of the aberrant signaling
cannot be restored to normal levels. As a consequence,
compensatory signaling pathways can be easily activated
in cells that have become imbalanced. We suggest that
inhibition of NFkB in breast cells could be one crucial
change that would allow these cells to reorganize and
thereby to re-integrate their signaling. The additional
details of how exactly the microenvironmental signals
reach NFkB and what are the other arms by which the
switch occurs require further investigation.

laminin-rich extracellular matrix (3D lrECM) on-top
cultures [37] were prepared by trypsinization of cells from
tissue culture plastic, seeding of single cells on top of a
thin gel of Engelbreth-Holm-Swarm (EHS) tumor extract
(Matrigel: BD Biosciences; Cultrex BME: Trevigen), and
addition of medium containing 5% EHS. S1 cells were
seeded at a density of 3.1×104 cells per cm2; T4 and BT549
cell lines were seeded at 2.1 ×104 cells per cm2. S1 and
T4-2 were maintained in their propagation medium with
media change every 2 days. BT549 cells were maintained
in H14 medium [7] with 1% fetal bovine serum.

Microarray hybridization and analysis.
S1, T4-2 and reverted T4 cells were isolated from
3D cultures with PBS/EDTA as previously described [37].
Purified total cellular RNA was extracted using RNeasy
Mini Kit with on-column DNase digestion (Qiagen).
RNA was quantified by measuring optical density at A260
and quality was verified by agarose gel electrophoresis.
Affymetrix microarray analysis was performed using the
Affymetrix HG-U133A High Throughput Array (HTA)
GeneChip system, generating two sets of data from two
separate array platforms (GPL3921 and GPL4685, GEO
database GSE50444). Preprocessing, normalization and
filtering was performed using R Bioconductor [38].MAS5
normalization was performed separately on the two sets of
expression data. ProbeIDs were filtered out if the average
log2 expression value was lower than 6.5. For genes with
more than one probeID, we only considered the one with
the highest variance. The two sets of expression values
were row-centered (mean and variance) separately and
then merged to one gene expression matrix. Unsupervised
hierarchical clustering analysis was performed with
Cluster (uncentered correlation, average linkage), and
results were visualized with TreeView (http://www.
eisenlab.org/eisen/?page_id=42). Gene set enrichment
analysis was performed with GSEA v2.07 (http://www.
broadinstitute.org/gsea/index.jsp, [21]). Network analysis
was performed with Cytoscape 2.7.0. Transcription factor
binding site analysis was performed using TransFind (-300
to 100 bp, top 500 genes, [22]). Potential targets of NFkB
transcriptional regulation were retrieved by repeated
transcription factor binding site analysis with subsets of
the disorganization signature using Transfind. DAVID
Gene Ontology was used to determine overrepresented
GO and KEGG terms [19].

MATERIALS AND METHODS

Virus production and transduction.

Cell culture.

For p65 shRNA production, a double-stranded
DNA oligonucleotide was generated from the following
sequences: sense,5’-GATCCGGACATATGAGACCTT
CAACTTCCTGTCAGATATATCTCTCCTTCCACAC
TTTTTG-3’; antisense,5’-AATTCAAAAAGGACATAT

HMT-3522 S1 and T4-2 cells were maintained on
tissue culture plastic as previously described [7]. BT549
cells were propagated in DMEM/F12 (Sigma) with 10%
fetal bovine serum (Invitrogen). Three dimensional
www.impactjournals.com/oncotarget
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GAGACCTTCAATCTGACAGGAAGTATATCTCTCC
TTCCACACG-3’ (target sequence underlined; BamH1/
EcoR1 cohesive ends italicized). Both oligonucleotides
were annealed and ligated into BamH1/EcoR1 site
of pGreen puro lentival vector (System Biosciences).
Lentivirus production and transduction of target cells were
conducted following guideline by System Biosciences.
Briefly, lentivirus vector and packaging plasmid mix
(System Biosciences) were transfected into 293FT cells
(Invitrogen) using Lipofectamine® 2000. After 48 hours,
medium was harvested, filtered and used to infect target
T4-2 cells with the addition of polybrene (10 µg/ml). After
24 hours medium was replaced. At 72 hours post-infection
puromycin (0.5 µg/ml) was added for selection and
maintained throughout the culturing period. shRNA vector
against RelB were from Open Biosystems. Retrovirus
production and infection protocol from the company were
followed.

vector pGL3 (Promega). T4-2 cells were co-transfected
with pGL-NF-κB and pNeo plasmid (1:10). Stably
transfected cells were isolated by G418 selection and
cultured in 3D in the presence of Tyrphostin. Following
treatment, equal amounts of cell lysates were assayed for
luciferase activity.
S1 and T4-2 cells were cultured in 3D for 10 days.
Total and nuclear protein was extracted from S1, T4-2, and
reverted T4 cells or nuclei. Western blot experiments were
performed as previously described [40]. After sonication,
insoluble material was removed by centrifugation at 15,000
g for 10 min. Proteins (20 µg) from each sample were
subjected to SDS gel electrophoresis and then transferred
to nitrocellulose membrane (Schleicher & Schuell). The
membrane was subsequently incubated in blocking buffer
containing primary antibody and horseradish peroxidaseconjugated secondary antibodies. The membrane was then
subjected to enhanced chemiluminescence (ECL) using
the SuperSignal chemiluminescent substrate (Pierce,
Rockford, IL).

Immunofluorescence and image acquisition.
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RT-PCR and real-time PCR.
Total RNA was extracted from cells using RNeasy
Mini Kit (Qiagen). cDNA was synthesized using
Superscript first strand synthesis kit (Invitrogen) from
0.5-1.0 μg RNA samples. Quantitative real-time PCR
analysis was performed with the Lightcycler System using
the Lightcycler FastStart DNA Master SYBR Green I kit
(Roche). The following Lightcycler PCR amplification
protocol was used: 95°C for 10 min (initial denaturation),
and 45 amplification cycles (95°C for 5 s, 60°C for 10
s, 72°C for 5 s). Amplification was followed by melting
curve analysis to verify the presence of a single PCR
product [39].
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